Mainz Biomed: Kim Turgeon

Mainz Biomed has appointed Kim Turgeon to its medical advisory board. Turgeon is a clinical professor at University of Michigan Health and a clinical translational researcher who specializes in colon cancer and chemoprevention. He also has been a co-lead of the Barrett's Esophagus Translational Research Network sponsored by the National Cancer Institute. 

Germany-based Mainz's medical advisory board is supporting an upcoming US trial for its ColoAlert DNA assay for markers of colorectal cancer as well as helping evaluate ColoAlert's potential uses in other oncology indications and potential to enhance Mainz's product pipeline.